Athanase Innovation AB (OSTO:ATIN) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Athanase Innovation AB EBITDA Margin % Related Terms
Athanase Innovation AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Athanase Innovation AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ATIN vs EVG, SMM, NHS: EBITDA Margin % Comparison
For the Asset Management subindustry, Athanase Innovation AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Athanase Innovation AB EBITDA Margin % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Athanase Innovation AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Athanase Innovation AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Athanase Innovation AB (OSTO:ATIN) has a EBITDA Margin % of 49,380.97% as of Dec. 2020. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Athanase Innovation AB and its competitors.
Is Athanase Innovation AB's EBITDA Margin % too high?
Athanase Innovation AB's current EBITDA Margin % is 49,380.97%. The Asset Management industry median EBITDA Margin % is 30.19. Athanase Innovation AB's value of 49,380.97% is 163494.4% above this industry median. Overall, Athanase Innovation AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Athanase Innovation AB's EBITDA Margin % compare to EVG and SMM?
Athanase Innovation AB's EBITDA Margin % of 49,380.97% can be compared against companies in the Asset Management industry. The industry median EBITDA Margin % is 30.19. Athanase Innovation AB's value of 49,380.97% is 163494.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Asset Management company?
The median EBITDA Margin % among Asset Management companies is 30.19, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Athanase Innovation AB's current EBITDA Margin % of 49,380.97% is 163494.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Athanase Innovation AB and its competitors. For the Asset Management industry, the median EBITDA Margin % is 30.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athanase Innovation AB's current EBITDA Margin % is 49,380.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athanase Innovation AB stock overvalued right now?
Athanase Innovation AB (OSTO:ATIN) has a current EBITDA Margin % of 49,380.97%. The current EBITDA Margin % is 49,380.97% and 163494.4% above the Asset Management industry median of 30.19. Athanase Innovation AB's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Athanase Innovation AB (OSTO:ATIN), the current EBITDA Margin % is 49,380.97% as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
26GF Score
Get the complete analysis for OSTO:ATIN
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ATIN has been successfully added to your 